ABC 7 News
May 20, 2026
John Gonzalez
Excerpt:
Supporters of the proposal argue that the soaring cost of GLP-1 medications has become unsustainable for government-funded health plans. State officials estimate the proposed cap on Ozempic alone could save nearly $6 million annually. The board previously approved a similar cost cap on Jardiance after determining the drug was considered “unaffordable” under Maryland law.
Under the proposal, the state would set what is known as an “upper payment limit” for certain government health plans, including plans covering state and local employees. The limits would not apply to private insurance plans or individual consumers directly.
View the full segment at Channel 7 News.
Last modified: May 21, 2026
